Literature DB >> 19428810

A novel glutaminase isoform in mammalian tissues.

Vanessa de la Rosa1, José A Campos-Sandoval, Mercedes Martín-Rufián, Carolina Cardona, José M Matés, Juan A Segura, Francisco J Alonso, Javier Márquez.   

Abstract

The synthesis of neurotransmitter glutamate in brain is mainly carried out by glutaminase enzymes. This synthesis must be exquisitely regulated because of its harmful potential giving rise to excitotoxic damage. It is noteworthy that two glutaminase isozymes coded by different genes are expressed in the brain of mammals. The need for two genes and two isozymes to support the single process of glutamate synthesis is unexplained, and identifying the role of each glutaminase is an important factor in understanding glutamate-mediated neurotransmission. Multiple transcripts for glutaminase genes and simultaneous expression of glutaminase isoforms have been reported in mammalian tissues and cells. The recent discovery of protein interacting partners widens the possibilities of regulatory mechanisms controlling these biosynthetic enzymes. The expression of distinct isozymes and binding partners may represent the biochemical and molecular basis to achieve fine-tuning control of glutamate synthesis in different cell types or developmental states. In this review, we will briefly summarize recent works on glutaminase proteins in mammals, with particular emphasis on brain studies. We present convergent evidence supporting the existence of a novel glutaminase isozyme in mammalian tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428810     DOI: 10.1016/j.neuint.2009.02.021

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  23 in total

1.  Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations.

Authors:  Qiuying Chen; Kathryne Kirk; Yevgeniya I Shurubor; Dazhi Zhao; Andrea J Arreguin; Ifrah Shahi; Federica Valsecchi; Guido Primiano; Elizabeth L Calder; Valerio Carelli; Travis T Denton; M Flint Beal; Steven S Gross; Giovanni Manfredi; Marilena D'Aurelio
Journal:  Cell Metab       Date:  2018-04-12       Impact factor: 27.287

2.  ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.

Authors:  Shuo Qie; Clarissa Chu; Weihua Li; Chenguang Wang; Nianli Sang
Journal:  J Cell Biochem       Date:  2014-03       Impact factor: 4.429

3.  Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

Authors:  Nathalie Jacque; Anne Marie Ronchetti; Clément Larrue; Godelieve Meunier; Rudy Birsen; Lise Willems; Estelle Saland; Justine Decroocq; Thiago Trovati Maciel; Mireille Lambert; Laury Poulain; Marie Anne Hospital; Pierre Sujobert; Laure Joseph; Nicolas Chapuis; Catherine Lacombe; Ivan Cruz Moura; Susan Demo; Jean Emmanuel Sarry; Christian Recher; Patrick Mayeux; Jérôme Tamburini; Didier Bouscary
Journal:  Blood       Date:  2015-07-17       Impact factor: 22.113

4.  Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types.

Authors:  Zheng Xia; Lawrence A Donehower; Thomas A Cooper; Joel R Neilson; David A Wheeler; Eric J Wagner; Wei Li
Journal:  Nat Commun       Date:  2014-11-20       Impact factor: 14.919

Review 5.  Targeting metabolism in breast cancer: How far we can go?

Authors:  Jing-Pei Long; Xiao-Na Li; Feng Zhang
Journal:  World J Clin Oncol       Date:  2016-02-10

Review 6.  A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis.

Authors:  William P Katt; Michael J Lukey; Richard A Cerione
Journal:  Future Med Chem       Date:  2017-01-23       Impact factor: 3.808

7.  Network of brain protein level changes in glutaminase deficient fetal mice.

Authors:  Narkhyun Bae; Yvonne Wang; Lin Li; Stephen Rayport; Gert Lubec
Journal:  J Proteomics       Date:  2013-01-30       Impact factor: 4.044

Review 8.  Glutamine Addiction In Gliomas.

Authors:  Javier Márquez; Francisco J Alonso; José M Matés; Juan A Segura; Mercedes Martín-Rufián; José A Campos-Sandoval
Journal:  Neurochem Res       Date:  2017-03-09       Impact factor: 3.996

9.  Kinetics of a novel isoform of phosphate activated glutaminase (PAG) in SH-SY5Y neuroblastoma cells.

Authors:  B A Roberg; I Aa Torgner; E Kvamme
Journal:  Neurochem Res       Date:  2009-10-27       Impact factor: 3.996

10.  Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.

Authors:  Mercedes Martín-Rufián; Renata Nascimento-Gomes; Ana Higuero; Amanda R Crisma; José A Campos-Sandoval; María C Gómez-García; Carolina Cardona; Tzuling Cheng; Carolina Lobo; Juan A Segura; Francisco J Alonso; Monika Szeliga; Jan Albrecht; Rui Curi; Javier Márquez; Alison Colquhoun; Ralph J Deberardinis; José M Matés
Journal:  J Mol Med (Berl)       Date:  2013-11-26       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.